Cargando…

Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions

Pituitary Gonadotropin-Releasing Hormone receptors (GnRH-R) mediate the activity of the hypothalamic decapeptide GnRH, thus playing a key role in the regulation of the reproductive axis. Early-stage prostate cancer (PCa) is dependent on serum androgen levels, and androgen-deprivation therapy (ADT),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fontana, Fabrizio, Marzagalli, Monica, Montagnani Marelli, Marina, Raimondi, Michela, Moretti, Roberta M., Limonta, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765031/ https://www.ncbi.nlm.nih.gov/pubmed/33327545 http://dx.doi.org/10.3390/ijms21249511

Ejemplares similares

Gonadotropin-Releasing Hormone Agonists Sensitize, and Resensitize, Prostate Cancer Cells to Docetaxel in a p53-Dependent Manner
por: Moretti, Roberta M., et al.
Publicado: (2014)

Role of Endoplasmic Reticulum Stress in the Anticancer Activity of Natural Compounds
por: Limonta, Patrizia, et al.
Publicado: (2019)

δ‐Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells
por: Fontana, Fabrizio, et al.
Publicado: (2019)

Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility
por: Marzagalli, Monica, et al.
Publicado: (2016)

Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells
por: Cristofani, Riccardo, et al.
Publicado: (2018)

Estrogen Receptor β Agonists Differentially Affect the Growth of Human Melanoma Cell Lines
por: Marzagalli, Monica, et al.
Publicado: (2015)

Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets
por: Fontana, Fabrizio, et al.
Publicado: (2020)

Cancer Stem Cells—Key Players in Tumor Relapse
por: Marzagalli, Monica, et al.
Publicado: (2021)

Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery
por: Fontana, Fabrizio, et al.
Publicado: (2020)

Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol
por: Marzagalli, Monica, et al.
Publicado: (2018)

Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells
por: Fontana, Fabrizio, et al.
Publicado: (2019)

δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis
por: Fontana, Fabrizio, et al.
Publicado: (2021)

Vitamin E δ-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells
por: Montagnani Marelli, Marina, et al.
Publicado: (2016)

Ca(2+) overload- and ROS-associated mitochondrial dysfunction contributes to δ-tocotrienol-mediated paraptosis in melanoma cells
por: Raimondi, Michela, et al.
Publicado: (2021)

Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer
por: Fontana, Fabrizio, et al.
Publicado: (2021)

In Vitro 3D Cultures to Model the Tumor Microenvironment
por: Fontana, Fabrizio, et al.
Publicado: (2021)

Melanoma Stem Cells Educate Neutrophils to Support Cancer Progression
por: Anselmi, Martina, et al.
Publicado: (2022)

Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells
por: Montagnani Marelli, Marina, et al.
Publicado: (2023)

A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
por: Asakawa, Jumpei, et al.
Publicado: (2018)

Adipocytes reprogram prostate cancer stem cell machinery
por: Fontana, Fabrizio, et al.
Publicado: (2023)

Unraveling the Peculiar Features of Mitochondrial Metabolism and Dynamics in Prostate Cancer
por: Fontana, Fabrizio, et al.
Publicado: (2023)

Firing patterns of gonadotropin-releasing hormone neurons are sculpted by their biologic state
por: Penix, Jonathon, et al.
Publicado: (2020)

Development of the gonadotropin‐releasing hormone system
por: Duittoz, Anne H., et al.
Publicado: (2022)

Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer
por: Choi, Seungtaek, et al.
Publicado: (2011)

Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for δ-Tocotrienol
por: Fontana, Fabrizio, et al.
Publicado: (2022)

Kisspeptin regulates gonadotropin-releasing hormone secretion in gonadotropin-releasing hormone/enhanced green fluorescent protein transgenic rats
por: Xue, Haogang, et al.
Publicado: (2013)

Invertebrate Gonadotropin-Releasing Hormone Receptor Signaling and Its Relevant Biological Actions
por: Sakai, Tsubasa, et al.
Publicado: (2020)

Apoptosis-mediated anticancer activity in prostate cancer cells of a chestnut honey (Castanea sativa L.) quinoline–pyrrolidine gamma-lactam alkaloid
por: Beretta, Giangiacomo, et al.
Publicado: (2021)

Reproductive responses of dairy cows with ovarian cysts to simultaneous human chorionic gonadotropin or gonadotropin-releasing hormone and cloprostenol compared to gonadotropin-releasing hormone alone treatment
por: Taktaz, T., et al.
Publicado: (2015)

Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011)

Epigenetic Control of Gonadotropin Releasing Hormone Neurons
por: Kurian, Joseph R., et al.
Publicado: (2013)

Mathematical modeling of gonadotropin-releasing hormone signaling
por: Pratap, Amitesh, et al.
Publicado: (2017)

Gonadotropin-releasing hormone: incredible 50 years
por: Paulson, Richard J., et al.
Publicado: (2023)

The Leaf Essential Oil of Myrtus communis subsp. tarentina (L.) Nyman: From Phytochemical Characterization to Cytotoxic and Antimigratory Activity in Human Prostate Cancer Cells
por: Giuliani, Claudia, et al.
Publicado: (2023)

Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018)

Apoptotic Death of Prostate Cancer Cells by a Gonadotropin-Releasing Hormone-II Antagonist
por: Park, Sumi, et al.
Publicado: (2014)

Increased Risk of Pneumonia in Patients Receiving Gonadotropin-Releasing Hormone Agonists for Prostate Cancer
por: Chung, Shiu-Dong, et al.
Publicado: (2014)

Progress in Clinical Research on Gonadotropin-Releasing Hormone Receptor Antagonists for the Treatment of Prostate Cancer
por: Liu, Yi-Fu, et al.
Publicado: (2021)

Hormone-induced sperm-release in the critically endangered Booroolong frog (Litoria booroolongensis): effects of gonadotropin-releasing hormone and human chorionic gonadotropin
por: Silla, Aimee J, et al.
Publicado: (2019)

The potential regulatory mechanisms of the gonadotropin-releasing hormone in gonadotropin transcriptions identified with bioinformatics analyses
por: Xiang, Wei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q1nlnog0f4b2g7d987bifdten3